Stockreport

What Happened With CAR-T Stocks in 2018 [The Motley Fool]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Here’s how CAR-T therapies did in their first full year on the market. Last year's launch of new gene therapy's called chimeric antigen receptor T-cell therapies [Read more]